Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain

JAMA ONCOLOGY

AMER MEDICAL ASSOC

1. NCI NIH HHS [P30 CA008748, P01 CA129243] Funding Source: Medline